An Open-Label Study Evaluating the Long-Term Efficacy, Quality of Life, and Safety of Lidose-Isotretinoin (ABSORICA) Capsules Administered Without Food in Patients with Severe Recalcitrant Nodular Acne: Interim Analysis of 20-Week Active Treatment Period

Main Article Content

Andrea Zaenglein
James Del Rosso

Keywords

acne, nodular acne, lidose-isotretinoin, retinoid

Abstract

Abstract not available.

 

Disclosures: Study supported by SUN Pharma.

 

Copyright 2018 SKIN

Article Sidebar

Poster PDF
Published
Feb 23, 2018
DOI https://doi.org/10.25251/skin.2.supp.32

Article Details

How to Cite
Zaenglein, A., & Del Rosso, J. (2018). An Open-Label Study Evaluating the Long-Term Efficacy, Quality of Life, and Safety of Lidose-Isotretinoin (ABSORICA) Capsules Administered Without Food in Patients with Severe Recalcitrant Nodular Acne: Interim Analysis of 20-Week Active Treatment Period. SKIN The Journal of Cutaneous Medicine, 2(S1), S33. https://doi.org/10.25251/skin.2.supp.32
Issue
Vol. 2 (2018): Supplemental Issue: Scientific Posters Presented at 2018 Winter Clinical Dermatology Conference®-Hawaii
Section
Acne & Rosacea
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors transfer copyright to the publisher as part of the journal publishing agreement.

All reprints are subject to the reprint policy.